<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35272709</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2047-9158</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>11</Day></PubDate></JournalIssue><Title>Translational neurodegeneration</Title><ISOAbbreviation>Transl Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Autologous treatment for ALS with implication for broad neuroprotection.</ArticleTitle><Pagination><StartPage>16</StartPage><MedlinePgn>16</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">16</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s40035-022-00290-5</ELocationID><Abstract><AbstractText Label="BACKGROUND">Amyotrophic lateral sclerosis (ALS) is characterized by a progressive loss of motor neurons (MNs), leading to paralysis, respiratory failure and death within 2-5&#xa0;years of diagnosis. The exact mechanisms of sporadic ALS, which comprises 90% of all cases, remain unknown. In familial ALS, mutations in superoxide dismutase (SOD1) cause 10% of cases.</AbstractText><AbstractText Label="METHODS">ALS patient-derived human-induced pluripotent stem cells (ALS hiPSCs, harboring the SOD1<sup>AV4</sup> mutation), were differentiated to MNs (ALS-MNs). The neuroprotective effects of conditioned medium (CM) of hESCs (H9), wt hiPSCs (WTC-11) and the ALS iPSCs, on MN apoptosis and viability, formation and maintenance of neurites, mitochondrial activity and expression of inflammatory genes, were examined. For in vivo studies, 200&#xa0;&#x3bc;l of CM from the ALS iPSCs (CS07 and CS053) was injected subcutaneously into the ALS model mice (transgenic for the human SOD1<sup>G93A</sup> mutation). Animal agility and strength, muscle innervation and mass, neurological score, onset of paralysis and lifespan of the ALS mice were assayed. After observing significant disease-modifying effects, the CM was characterized biochemically by fractionation, comparative proteomics, and epigenetic screens for the dependence on pluripotency. CM of fibroblasts that were differentiated from the wt hiPSCs lacked any neuroprotective activity and was used as a negative control throughout the studies.</AbstractText><AbstractText Label="RESULTS">The secretome of PSCs including the ALS patient iPSCs was neuroprotective in the H<sub>2</sub>O<sub>2</sub> model. In the model with pathogenic SOD1 mutation, ALS iPSC-CM attenuated all examined hallmarks of ALS pathology, rescued human ALS-MNs from denervation and death, restored mitochondrial health, and reduced the expression of inflammatory genes. The ALS iPSC-CM also improved neuro-muscular health and function, and&#xa0;delayed paralysis and morbidity in ALS mice. Compared side by side, cyclosporine (CsA), a mitochondrial membrane blocker that prevents the leakage of mitochondrial DNA, failed to avert the death of ALS-MNs, although CsA and ALS iPSC-CM equally stabilized MN mitochondria and attenuated inflammatory genes. Biochemical characterization, comparative proteomics, and epigenetic screen all suggested that it was the interactome of several key proteins from different fractions of PSC-CM that delivered the multifaceted neuroprotection.</AbstractText><AbstractText Label="CONCLUSIONS">This work introduces and mechanistically characterizes a new biologic for treating ALS and other complex neurodegenerative diseases.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Daehwan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Subin</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Neetika</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conboy</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Conboy</LastName><ForeName>Irina M</ForeName><Initials>IM</Initials><Identifier Source="ORCID">0000-0002-4276-0644</Identifier><AffiliationInfo><Affiliation>Department of Bioengineering and QB3 Institute, University of California, Berkeley, CA, 94720, USA. iconboy@berkeley.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG071787</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 EB023776</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL139605</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Transl Neurodegener</MedlineTA><NlmUniqueID>101591861</NlmUniqueID><ISSNLinking>2047-9158</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C531617">Amyotrophic lateral sclerosis 1</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000066829" MajorTopicYN="N">Neuroprotection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010243" MajorTopicYN="N">Paralysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">SOD1 mutation</Keyword><Keyword MajorTopicYN="N">Secretome</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest in this manuscript.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>5</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35272709</ArticleId><ArticleId IdType="pmc">PMC8915496</ArticleId><ArticleId IdType="doi">10.1186/s40035-022-00290-5</ArticleId><ArticleId IdType="pii">10.1186/s40035-022-00290-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Check WA. Amyotrophic lateral sclerosis. JAMA. 1979;242(4):319.</Citation><ArticleIdList><ArticleId IdType="pubmed">448927</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoyama K, Nakaki T. Impaired glutathione synthesis in neurodegeneration. Int J Mol Sci. 2013;14:21021&#x2013;21044.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3821656</ArticleId><ArticleId IdType="pubmed">24145751</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775.</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Rakhit R, Cunningham P, Furtos-Matei A, Dahan S, Qi XF, Crow JP, et al. Oxidation-induced misfolding and aggregation of superoxide dismutase and its implications for amyotrophic lateral sclerosis. J Biol Chem. 2002;277:47551&#x2013;47556.</Citation><ArticleIdList><ArticleId IdType="pubmed">12356748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi SA, Urushitani M, Julien JP. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J Neurochem. 2007;102:170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">17394546</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber SC, Mead RJ, Shaw PJ. Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta. 2006;1762(11&#x2013;12):1051&#x2013;1067.</Citation><ArticleIdList><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Rotunno MS, Bosco DA. An emerging role for misfolded wild-type SOD1 in sporadic ALS pathogenesis. Front Cell Neurosci. 2013;7:253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3863749</ArticleId><ArticleId IdType="pubmed">24379756</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston JA, Dalton MJ, Gurney ME, Kopito RR. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2000;97:12571&#x2013;12576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC18805</ArticleId><ArticleId IdType="pubmed">11050163</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci. 2006;9:408&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita T, Kushida Y, Wakao S, Tadokoro K, Nomura E, Omote Y, et al. Therapeutic benefit of Muse cells in a mouse model of amyotrophic lateral sclerosis. Sci Rep. 2020;10:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7554047</ArticleId><ArticleId IdType="pubmed">33051552</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Kriz J, Gravel M, Soucy G, Bareil C, Gravel C, et al. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis. Mol Ther. 2014;22:498&#x2013;510.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3944333</ArticleId><ArticleId IdType="pubmed">24394188</ArticleId></ArticleIdList></Reference><Reference><Citation>Zakrzewski W, Dobrzy&#x144;ski M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther. 2019;10(1):68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6390367</ArticleId><ArticleId IdType="pubmed">30808416</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley L, Allodi I, Nichterwitz S, Nizzardo M, Simone C, Corti S, et al. Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience. 2015;291:216&#x2013;229.</Citation><ArticleIdList><ArticleId IdType="pubmed">25697826</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, Atsuta N, Nakamura R, Akiyama T, et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24:1579&#x2013;1589.</Citation><ArticleIdList><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, et al. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell. 2014;14:796&#x2013;809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4230530</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Ona VO, Gu&#xe9;gan C, Chen M, Jackson-Lewis V, Andrews LJ, et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science. 2000;288:335&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">10764647</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostic V, Jackson-Lewis V, De Bilbao F, Dubois-Dauphin M, Przedborski S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 1997;277:559&#x2013;562.</Citation><ArticleIdList><ArticleId IdType="pubmed">9228005</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Aranda I, Ramos-Mejia V, Bueno C, Munoz-Lopez M, Real PJ, M&#xe1;cia A, et al. Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells. 2010;28(9):1568&#x2013;1570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2996086</ArticleId><ArticleId IdType="pubmed">20641038</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef H, Conboy MJ, Mamiya H, Zeiderman M, Schlesinger C, Schaffer DV, et al. Mechanisms of action of hESC-secreted proteins that enhance human and mouse myogenesis. Aging (Albany NY) 2014;6:602&#x2013;620.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4169857</ArticleId><ArticleId IdType="pubmed">25109702</ArticleId></ArticleIdList></Reference><Reference><Citation>Yousef H, Conboy MJ, Li J, Zeiderman M, Vazin T, Schlesinger C, et al. hESC-secreted proteins can be enriched for multiple regenerative therapies by heparin-binding. Aging (Albany NY) 2013;5:357&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3701111</ArticleId><ArticleId IdType="pubmed">23793469</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuoka H, Suga H, Narita K, Watanabe R, Shintani S. The latest advance in hair regeneration therapy using proteins secreted by adipose-derived stem cells. Am J Cosmet Surg. 2012;29:273&#x2013;282.</Citation></Reference><Reference><Citation>Sagaradze G, Grigorieva O, Nimiritsky P, Basalova N, Kalinina N, Akopyan Z, et al. Conditioned medium from human mesenchymal stromal cells: towards the clinical translation. Int J Mol Sci. 2019;20:1656.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6479925</ArticleId><ArticleId IdType="pubmed">30987106</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang D, Wang W, Li L, Peng Y, Chen P, Huang H, et al. The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair. PLoS ONE. 2013;8:e59020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3602597</ArticleId><ArticleId IdType="pubmed">23527076</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi M, Li TS, Suzuki R, Kobayashi T, Ito H, Ikeda Y, et al. Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. Am J Physiol. 2006;291:886&#x2013;893.</Citation><ArticleIdList><ArticleId IdType="pubmed">16603697</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu Q, Li D, Louis KR, Li X, Yang H, Sun Q, et al. High-efficiency motor neuron differentiation from human pluripotent stem cells and the function of Islet-1. Nat Commun. 2014;5:3449.</Citation><ArticleIdList><ArticleId IdType="pubmed">24622388</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Zhang L, Li Y, Chen L, Wang X, Guo W, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61&#x2013;69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4469495</ArticleId><ArticleId IdType="pubmed">26000464</ArticleId></ArticleIdList></Reference><Reference><Citation>Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43:W566&#x2013;W570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4489295</ArticleId><ArticleId IdType="pubmed">25969447</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanilla CV, Gu H, Liu Q, Zhu TZ, Zhou C, Johnstone BH, et al. Adipose-derived stem cell conditioned media extends survival time of a mouse model of amyotrophic lateral sclerosis. Sci Rep. 2015;5:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653659</ArticleId><ArticleId IdType="pubmed">26586020</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatzipetros T, Kidd JD, Moreno AJ, Thompson K, Gill A, Vieira FG. A quick phenotypic neurological scoring system for evaluating disease progression in the SOD1-G93A mouse model of ALS. J Vis Exp. 2015;2015:53257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4692639</ArticleId><ArticleId IdType="pubmed">26485052</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai MD, Choi SM, Yang EJ. The effects of bee venom acupuncture on the central nervous system and muscle in an animal hsOD1G93A mutant. Toxins (Basel) 2015;7:846&#x2013;858.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4379529</ArticleId><ArticleId IdType="pubmed">25781653</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Zuzzio K, Walker CL. Systemic dental pulp stem cell secretome therapy in a mouse model of amyotrophic lateral sclerosis. Brain Sci. 2019;9:165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6680809</ArticleId><ArticleId IdType="pubmed">31337114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigarella CL, Liang R, Ghaffari S. Stem cells and the impact of ROS signaling. Development. 2014;141:4206&#x2013;4218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4302918</ArticleId><ArticleId IdType="pubmed">25371358</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarng DC, Tseng WC, Lee PY, Chiou SH, Hsieh SL. Induced pluripotent stem cell-derived conditioned medium attenuates acute kidney injury by downregulating the oxidative stress-related pathway in ischemia&#x2013;reperfusion rats. Cell Transplant. 2016;25:517&#x2013;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">26132529</ArticleId></ArticleIdList></Reference><Reference><Citation>Alves CJ, De Santana LP, Dos Santos AJD, De Oliveira GP, Duobles T, Scorisa JM, et al. Early motor and electrophysiological changes in transgenic mouse model of amyotrophic lateral sclerosis and gender differences on clinical outcome. Brain Res. 2011;1394:90&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">21354109</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovich-Toidman P, Rabinovich-Nikitin I, Ezra A, Barbiro B, Fogel H, Slutsky I, et al. Mutant SOD1 increases APP expression and phosphorylation in cellular and animal models of ALS. PLoS ONE. 2015;10:e0143420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4658003</ArticleId><ArticleId IdType="pubmed">26600047</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenggeli C, Julien JP, Lee Mosley R, Perez N, Dhar A, Gendelman HE, et al. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS. Neurobiol Dis. 2007;26:146&#x2013;152.</Citation><ArticleIdList><ArticleId IdType="pubmed">17276077</ArticleId></ArticleIdList></Reference><Reference><Citation>Ari C, Poff AM, Held HE, Landon CS, Goldhagen CR, Mavromates N, et al. Metabolic therapy with deanna protocol supplementation delays disease progression and extends survival in amyotrophic lateral sclerosis (ALS) mouse model. PLoS ONE. 2014;9(7):e103526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4111621</ArticleId><ArticleId IdType="pubmed">25061944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V, Francolini M. Neuromuscular junction dismantling in amyotrophic lateral sclerosis. Int J Mol Sci. 2017;18(10):2092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Chem Neuroanat. 2016;76:35&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, Bauch&#xe9; S, Gonzalez de Aguilar JL, Brochier G, Mandjee N, et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol. 2015;2:362&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Basu J, Ludlow JW. Exosomes for repair, regeneration and rejuvenation. Expert Opin Biol Ther. 2016;16:489&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pubmed">26817494</ArticleId></ArticleIdList></Reference><Reference><Citation>Duffy LM, Chapman AL, Shaw PJ, Grierson AJ. Review: the role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis. Neuropathol Appl Neurobiol. 2011;37(4):336&#x2013;352.</Citation><ArticleIdList><ArticleId IdType="pubmed">21299590</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith EF, Shaw PJ, De Vos KJ. The role of mitochondria in amyotrophic lateral sclerosis. Neurosci Lett. 2019;710:132933.</Citation><ArticleIdList><ArticleId IdType="pubmed">28669745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sultani M, Stringer AM, Bowen JM, Gibson RJ. Anti-inflammatory cytokines: important immunoregulatory factors contributing to chemotherapy-induced gastrointestinal mucositis. Chemother Res Pract. 2012;2012:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3437608</ArticleId><ArticleId IdType="pubmed">22973511</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B, Hong JS. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther. 2003;304:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">12490568</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu CH, Davidson S, Harapas CR, Hilton JB, Mlodzianoski MJ, Laohamonthonkul P, et al. TDP-43 triggers mitochondrial DNA release via mPTP to activate cGAS/STING in ALS. Cell. 2020;183:636&#x2013;649.e18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599077</ArticleId><ArticleId IdType="pubmed">33031745</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakamoto K, Karelina K, Obrietan K. CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem. 2011;116:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575743</ArticleId><ArticleId IdType="pubmed">21044077</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JY, Hong YT, Chuang JI. Fibroblast growth factor 9 prevents MPP+-induced death of dopaminergic neurons and is involved in melatonin neuroprotection in vivo and in vitro. J Neurochem. 2009;109:1400&#x2013;1412.</Citation><ArticleIdList><ArticleId IdType="pubmed">19476551</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian V, Crabtree B, Acharya KR. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet. 2008;17:130&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pubmed">17916583</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S, Wu H, Zeng C, Xiong X, Tang S, Tang Z, et al. Apolipoprotein E protects astrocytes from hypoxia and glutamate-induced apoptosis. FEBS Lett. 2013;587:254&#x2013;258.</Citation><ArticleIdList><ArticleId IdType="pubmed">23238080</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejima E, Guo S, Murata Y, Arai K, Lok J, Van Leyen K, et al. Neuroprotective effects of overexpressing tissue inhibitor of metalloproteinase TIMP-1. J Neurotrauma. 2009;26:1935&#x2013;1941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2822804</ArticleId><ArticleId IdType="pubmed">19469687</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao C, Borgmann K, Brew K, Ghorpade A. Tissue inhibitor of metalloproteinases-1 protects human neurons from staurosporine and HIV-1-induced apoptosis: Mechanisms and relevance to HIV-1-associated dementia. Cell Death Dis. 2012;3:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3388228</ArticleId><ArticleId IdType="pubmed">22739984</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh HD, Zheng J, Umikawa M, Zhang C, Silvany R, Iizuka S, et al. IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells. Blood. 2011;118:3236&#x2013;3243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179393</ArticleId><ArticleId IdType="pubmed">21821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Migita T, Narita T, Asaka R, Miyagi E, Nagano H, Nomura K, et al. Role of insulin-like growth factor binding protein 2 in lung adenocarcinoma: IGF-independent antiapoptotic effect via caspase-3. Am J Pathol. 2010;176:1756&#x2013;1766.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2843467</ArticleId><ArticleId IdType="pubmed">20150439</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher L, Isgor E, Sprague S, Williams LH, Alajajian BB, Jimenez DF, et al. Spatial distribution of insulin-like growth factor binding protein-2 following hypoxic-ischemic injury. BMC Neurosci. 2013;14:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3911968</ArticleId><ArticleId IdType="pubmed">24359611</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein TD, Anders NJ, DeCarli C, Chan SL, Mattson MP, Johnson JA. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci. 2004;24:7707&#x2013;7717.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6729623</ArticleId><ArticleId IdType="pubmed">15342738</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar MT, Lundberg AMC, Liu K, Vidyadaran S, Wells KE, Dolatshad H, et al. The neuroprotective effects of heat shock protein 27 overexpression in transgenic animals against kainate-induced seizures and hippocampal cell death. J Biol Chem. 2003;278:19956&#x2013;19965.</Citation><ArticleIdList><ArticleId IdType="pubmed">12639970</ArticleId></ArticleIdList></Reference><Reference><Citation>Toth ME, Gonda S, Vigh L, Santha M. Neuroprotective effect of small heat shock protein, Hsp27, after acute and chronic alcohol administration. Cell Stress Chaperones. 2010;15:807&#x2013;817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3024073</ArticleId><ArticleId IdType="pubmed">20461564</ArticleId></ArticleIdList></Reference><Reference><Citation>Venugopal A, Sundaramoorthy K, Vellingiri B. Therapeutic potential of Hsp27 in neurological diseases. Egypt J Med Hum Genet. 2019;20:1&#x2013;8.</Citation></Reference><Reference><Citation>Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson&#x2019;s disease. J Parkinsons Dis. 2013;3:461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4135313</ArticleId><ArticleId IdType="pubmed">24252804</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang WJ, Zhang X, Chen WW. Role of oxidative stress in Alzheimer&#x2019;s disease. Biomed Rep. 2016;4:519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4840676</ArticleId><ArticleId IdType="pubmed">27123241</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang SE, Qiu L, Chan LL, Tan EK, Zeng L. Current status of stem cell-derived therapies for Parkinson&#x2019;s disease: from cell assessment and imaging modalities to clinical trials. Front Neurosci. 2020;14:558532.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596695</ArticleId><ArticleId IdType="pubmed">33177975</ArticleId></ArticleIdList></Reference><Reference><Citation>Song CG, Zhang YZ, Wu HN, Cao XL, Guo CJ, Li YQ, et al. Stem cells: a promising candidate to treat neurological disorders. Neural Regen Res. 2018;13:1294&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6065243</ArticleId><ArticleId IdType="pubmed">30028342</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka J, Kostiuk V, Fereydooni A, Gonzalez L, Luo J, Dash B, et al. The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther. 2019;10(1):87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6416973</ArticleId><ArticleId IdType="pubmed">30867069</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldner F, Lagani&#xe8;re J, Cheng AW, Hockemeyer D, Gao Q, Alagappan R, et al. Generation of isogenic pluripotent stem cells differing exclusively at two early onset parkinson point mutations. Cell. 2011;146:318&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3155290</ArticleId><ArticleId IdType="pubmed">21757228</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker BA, Mullins RF, Streb LM, Anfnson K, Eyestone ME, Kaalberg E, et al. Patient-specifc iPSC-derived photoreceptor precursor cells as a means to investigate retinitis pigmentosa. Elife. 2013;2013(2):e00824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3755341</ArticleId><ArticleId IdType="pubmed">23991284</ArticleId></ArticleIdList></Reference><Reference><Citation>Douvaras P, Wang J, Zimmer M, Hanchuk S, O&#x2019;Bara MA, Sadiq S, et al. Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells. Stem Cell Rep. 2014;3:250&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176529</ArticleId><ArticleId IdType="pubmed">25254339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez-Begne M, Lu B, Han X, Hagen FK, Hand AR, Melvin JE, et al. Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT) J Proteome Res. 2009;8:1304&#x2013;1314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2693447</ArticleId><ArticleId IdType="pubmed">19199708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW, Jung JW, et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res. 2012;11:839&#x2013;849.</Citation><ArticleIdList><ArticleId IdType="pubmed">22148876</ArticleId></ArticleIdList></Reference><Reference><Citation>Pires AO, Mendes-Pinheiro B, Teixeira FG, Anjo SI, Ribeiro-Samy S, Gomes ED, et al. Unveiling the differences of secretome of human bone marrow mesenchymal stem cells, adipose tissue-derived stem cells, and human umbilical cord perivascular cells: a proteomic analysis. Stem Cells Dev. 2016;25:1073&#x2013;1083.</Citation><ArticleIdList><ArticleId IdType="pubmed">27226274</ArticleId></ArticleIdList></Reference><Reference><Citation>Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, et al. ApoE influences amyloid-&#x3b2; (A&#x3b2;) clearance despite minimal apoE/A&#x3b2; association in physiological conditions. Proc Natl Acad Sci USA. 2013;110:E1807&#x2013;E1816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651443</ArticleId><ArticleId IdType="pubmed">23620513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sebasti&#xe0; J, Kieran D, Breen B, King MA, Netteland DF, Joyce D, et al. Angiogenin protects motoneurons against hypoxic injury. Cell Death Differ. 2009;16:1238&#x2013;1247.</Citation><ArticleIdList><ArticleId IdType="pubmed">19444281</ArticleId></ArticleIdList></Reference><Reference><Citation>Kieran D, Sebastia J, Greenway MJ, King MA, Connaughton D, Concannon CG, et al. Control of motoneuron survival by angiogenin. J Neurosci. 2008;28:14056&#x2013;14061.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671464</ArticleId><ArticleId IdType="pubmed">19109488</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Zhang F, Yang J, Han S. Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis. Exp Neurol. 2014;261:245&#x2013;257.</Citation><ArticleIdList><ArticleId IdType="pubmed">24852101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosacka J, Figiel M, Engele J, Hilbig H, Majewski M, Spanel-Borowski K. Angiopoietin-1 promotes neurite outgrowth from dorsal root ganglion cells positive for Tie-2 receptor. Cell Tissue Res. 2005;320:11&#x2013;19.</Citation><ArticleIdList><ArticleId IdType="pubmed">15714275</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin J, Gong G, Liu X. Angiopoietin: a novel neuroprotective/neurotrophic agent. Neuroscience. 2019;411:177&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">31152935</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel YJK, Payne Smith MD, De Belleroche J, Latchman DS. Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Mol Brain Res. 2005;134:256&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pubmed">15836922</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YT, Tsai MJ, Hsieh N, Lo MJ, Lee MJ, Cheng H, et al. The superiority of conditioned medium derived from rapidly expanded mesenchymal stem cells for neural repair. Stem Cell Res Ther. 2019;10:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6916259</ArticleId><ArticleId IdType="pubmed">31842998</ArticleId></ArticleIdList></Reference><Reference><Citation>Hilkens P, Fanton Y, Martens W, Gervois P, Struys T, Politis C, et al. Pro-angiogenic impact of dental stem cells in vitro and in vivo. Stem Cell Res. 2014;12:778&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pubmed">24747218</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparicio-Erriu IM, Prehn JHM. Molecular mechanisms in amyotrophic lateral sclerosis: the role of angiogenin, a secreted rnase. Front Neurosci. 2012;6:167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500830</ArticleId><ArticleId IdType="pubmed">23181008</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian V, Feng Y. A new role for angiogenin in neurite growth and pathfinding: implications for amyotrophic lateral sclerosis. Hum Mol Genet. 2007;16:1445&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pubmed">17468498</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang J, Hu J, Shen T, Liu B, Hua F, Zan K, et al. Bone marrow mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke in type 2 diabetic rats. Neurosci Lett. 2017;644:62&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">28219791</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Q, Hu J, Xiang J, Gu Y, Jin P, Hua F, et al. Intranasal administration of human umbilical cord mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke. Brain Res. 2015;1624:489&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pubmed">26279113</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol. 2003;139:329&#x2013;336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1573855</ArticleId><ArticleId IdType="pubmed">12770938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakthisaran R, Tangirala R, Rao CM. Small heat shock proteins: role in cellular functions and pathology. Biochim Biophys Acta. 2015;1854:291&#x2013;319.</Citation><ArticleIdList><ArticleId IdType="pubmed">25556000</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeks SD, Muranova LK, Heirbaut M, Beelen S, Strelkov SV, Gusev NB. Characterization of human small heat shock protein HSPB1 &#x3b1;-crystallin domain localized mutants associated with hereditary motor neuron diseases. Sci Rep. 2018;8:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5766566</ArticleId><ArticleId IdType="pubmed">29330367</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu AL, Fuchshofer R, Birke M, Kampik A, Bloemendal H, Welge-L&#xfc;ssen U. Oxidative stress and TGF-&#x3b2;2 increase heat shock protein 27 expression in human optic nerve head astrocytes. Investig Ophthalmol Vis Sci. 2008;49:5403&#x2013;5411.</Citation><ArticleIdList><ArticleId IdType="pubmed">18552392</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf3;th ME, Szegedi V, Varga E, Juh&#xe1;sz G, Horv&#xe1;th J, Borb&#xe9;ly E, et al. Overexpression of Hsp27 ameliorates symptoms of Alzheimer&#x2019;s disease in APP/PS1 mice. Cell Stress Chaperones. 2013;18:759&#x2013;771.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3789881</ArticleId><ArticleId IdType="pubmed">23605646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou BR, Xu Y, Xu Y, Guo SL, Wang Y, Zhu F, et al. The effect of conditioned media of Adipose-derived stem cells on wound healing after ablative fractional carbon dioxide laser resurfacing. Biomed Res Int. 2013;2013.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3867954</ArticleId><ArticleId IdType="pubmed">24381938</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay AG, Long G, Tyler G, Stefan A, Broadfoot SJ, Piccinini AM, et al. Mesenchymal stem cell-conditioned medium reduces disease severity and immune responses in inflammatory arthritis. Sci Rep. 2017;7:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5740178</ArticleId><ArticleId IdType="pubmed">29269885</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahbour S, Jamali F, Alhattab D, Al-Radaideh A, Ababneh O, Al-Ryalat N, et al. Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: clinical, ophthalmological and radiological assessments of safety and efficacy. CNS Neurosci Ther. 2017;23:866&#x2013;874.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5698713</ArticleId><ArticleId IdType="pubmed">28961381</ArticleId></ArticleIdList></Reference><Reference><Citation>Pawitan JA. Prospect of stem cell conditioned medium in regenerative medicine. Biomed Res Int. 2014;2014.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229962</ArticleId><ArticleId IdType="pubmed">25530971</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland MJ, Nazor KL, Loring JF. Epigenetic regulation of pluripotency and differentiation. Circ Res. 2014;115:311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4229506</ArticleId><ArticleId IdType="pubmed">24989490</ArticleId></ArticleIdList></Reference><Reference><Citation>Sparmann A, Van Lohuizen M. Polycomb silencers control cell fate, development and cancer [Internet] Nat Rev Cancer. 2006;6:846&#x2013;856.</Citation><ArticleIdList><ArticleId IdType="pubmed">17060944</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Carroll D, Erhardt S, Pagani M, Barton SC, Surani MA, Jenuwein T. The polycomb -group gene Ezh2 is required for early mouse development. Mol Cell Biol. 2001;21:4330&#x2013;4336.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC87093</ArticleId><ArticleId IdType="pubmed">11390661</ArticleId></ArticleIdList></Reference><Reference><Citation>Collinson A, Collier AJ, Morgan NP, Sienerth AR, Chandra T, Andrews S, et al. Deletion of the polycomb-group protein EZH2 leads to compromised self-renewal and differentiation defects in human embryonic stem cells. Cell Rep. 2016;17:2700&#x2013;2714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177603</ArticleId><ArticleId IdType="pubmed">27926872</ArticleId></ArticleIdList></Reference><Reference><Citation>Sher F, R&#xf6;&#xdf;ler R, Brouwer N, Balasubramaniyan V, Boddeke E, Copray S. Differentiation of neural stem cells into oligodendrocytes: involvement of the polycomb group protein Ezh2. Stem Cells. 2008;26:2875&#x2013;2883.</Citation><ArticleIdList><ArticleId IdType="pubmed">18687996</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki R, Chiba T, Miyagi S, Negishi M, Konuma T, Taniguchi H, et al. The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells. J Hepatol. 2010;52:854&#x2013;863.</Citation><ArticleIdList><ArticleId IdType="pubmed">20395008</ArticleId></ArticleIdList></Reference><Reference><Citation>Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell. 2009;36:61&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2761245</ArticleId><ArticleId IdType="pubmed">19818710</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao Y, Hu H, Yang Y, Zhou G, Shang Z, Yang X, et al. Downregulation of enhancer of zeste homolog 2 (EZH2) is essential for the induction of autophagy and apoptosis in colorectal cancer cells. Genes (Basel) 2016;7:83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5083922</ArticleId><ArticleId IdType="pubmed">27706111</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi W, Chan HM, Teng L, Li L, Chuai S, Zhang R, et al. Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation. Proc Natl Acad Sci U S A. 2012;109:21360&#x2013;21365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3535655</ArticleId><ArticleId IdType="pubmed">23236167</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YC, Chang WW, Chen YY, Tsai YH, Chou YH, Tseng HC, et al. Hsp90&#x3b1; mediates BMI1 expression in breast cancer stem/progenitor cells through facilitating nuclear translocation of c-Myc and EZH2. Int J Mol Sci. 2017;18:1986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5618635</ArticleId><ArticleId IdType="pubmed">28914785</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q, He S, Tian Y, Gu Y, Chen P, Li C, et al. Hsp90 inhibition destabilizes Ezh2 protein in alloreactive T cells and reduces graft-versus-host disease in mice. Blood. 2017;129:2737&#x2013;2748.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5437825</ArticleId><ArticleId IdType="pubmed">28246193</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore HM, Gonzalez ME, Toy KA, Cimino-Mathews A, Argani P, Kleer CG. EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. Breast Cancer Res Treat. 2013;138:741&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3690767</ArticleId><ArticleId IdType="pubmed">23539298</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Merchan A, Arranz L, Ligos JM, De Molina A, Dominguez O, Gonzalez S. Ectopic expression of the histone methyltransferase Ezh2 in haematopoietic stem cells causes myeloproliferative disease. Nat Commun. 2012;3:1&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">22233633</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo YL, Chakraborty S, Rajan SS, Wang R, Huang F. Effects of oxidative stress on mouse embryonic stem cell proliferation, apoptosis, senescence, and self-renewal. Stem Cells Dev. 2010;19:1321&#x2013;1331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3128305</ArticleId><ArticleId IdType="pubmed">20092403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Khvorostov I, Hong JS, Oktay Y, Vergnes L, Nuebel E, et al. UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells. EMBO J. 2011;30:4860&#x2013;4873.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243621</ArticleId><ArticleId IdType="pubmed">22085932</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Lindgren AG, Srivastava AS, Clark AT, Banerjee U. Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells. 2011;29:486&#x2013;495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4374603</ArticleId><ArticleId IdType="pubmed">21425411</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou W, Choi M, Margineantu D, Margaretha L, Hesson J, Cavanaugh C, et al. HIF1&#x3b1; induced switch from bivalent to exclusively glycolytic metabolism during ESC-to-EpiSC/hESC transition. EMBO J. 2012;31:2103&#x2013;2116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3343469</ArticleId><ArticleId IdType="pubmed">22446391</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue H, Tsukita K, Iwasato T, Suzuki Y, Tomioka M, Tateno M, et al. The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. EMBO J. 2003;22:6665&#x2013;6674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC291829</ArticleId><ArticleId IdType="pubmed">14657037</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen WA, Luo H, Kruman I, Kasarskis E, Mattson MP. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J. 2000;14:913&#x2013;924.</Citation><ArticleIdList><ArticleId IdType="pubmed">10783145</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero EN, Mitra J, Wang H, Rangaswamy S, Hegde PM, Basu P, et al. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis. Hum Mol Genet. 2019;28:2459&#x2013;2476.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6659010</ArticleId><ArticleId IdType="pubmed">31067307</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathasivam S, Shaw PJ. Apoptosis in amyotrophic lateral sclerosis&#x2014;what is the evidence? Lancet Neurol. 2005;4:500&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pubmed">16033692</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>